- Supported exchanges /
- NSE /
- VINEETLAB.NSE
Vineet Laboratories Limited (VINEETLAB NSE) stock market data APIs
Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and fine chemicals in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde. The company was founded in 2007 and is based in Hyderabad, India.
Vineet Laboratories Limited Financial Data Overview
| 50.28 | |
| 51.27 | |
| - | |
| 51.44 | |
| 49.65 | |
| 47-88.9 | |
| 472 M | |
| 9 219 K | |
| 1 369 M | |
| -0.28 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Vineet Laboratories Limited Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 369 M
- EBITDA 60 145 K
- Earnings Per Share -4.45
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Vineet Laboratories Limited Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get Vineet Laboratories Limited End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
